Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article from Memory Care Business referenced a review published in a September 2022 supplement to The American Journal of Managed Care® (AJMC®) focusing on advancing Alzheimer disease treatment. The supplement article, “The Economic and Societal Burden of Alzheimer Disease: Managed Care Considerations,” highlighted that Alzheimer disease treatment could cost an estimated $321 billion in 2022, with costs expected to increase to $1 trillion in 2050.
An article from Business A.M. referenced a contributor article published on AJMC.com, the website of AJMC. The article, “Contributor: In the Misdiagnosis of Menopause, What Needs to Change?” highlighted that 80% of medical residents felt barely comfortable discussing menopause and only 20% of residency programs for obstetrics and gynecology offered menopause training.
Health Equity & Access Weekly Roundup: November 23, 2024
November 23rd 2024Americans are underinsured, even with employer-based health plans; a thorough critique of the lack of representation among Black patients in clinical trials showcases a persistent theme; systemic barriers in cardiology, breast cancer, and patent systems are examined.
Read More